These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28138666)

  • 1. Double-stranded RNA-binding artificial cationic oligosaccharides stabilizing siRNAs with a low N/P ratio.
    Hara RI; Maeda Y; Sakamoto T; Wada T
    Org Biomol Chem; 2017 Feb; 15(7):1710-1717. PubMed ID: 28138666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of oligodiaminogalactoses that bind to A-type oligonucleotide duplexes.
    Shiraishi T; Sato K; Hara RI; Wada T
    Org Biomol Chem; 2022 Nov; 20(42):8243-8258. PubMed ID: 36222332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial cationic oligosaccharides for heteroduplex oligonucleotide-type drugs.
    Hara RI; Hisada Y; Maeda Y; Yokota T; Wada T
    Sci Rep; 2018 Mar; 8(1):4323. PubMed ID: 29531343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and properties of double-stranded RNA-bindable oligodiaminogalactose derivatives conjugated with vitamin E.
    Iwata R; Nishina K; Yokota T; Wada T
    Bioorg Med Chem; 2014 Feb; 22(4):1394-403. PubMed ID: 24462177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An artificial cationic oligosaccharide combined with phosphorothioate linkages strongly improves siRNA stability.
    Irie A; Sato K; Hara RI; Wada T; Shibasaki F
    Sci Rep; 2020 Sep; 10(1):14845. PubMed ID: 32908235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of oligodiaminomannoses and analysis of their RNA duplex binding properties and their potential application as siRNA-based drugs.
    Iwata R; Doi A; Maeda Y; Wada T
    Org Biomol Chem; 2015 Sep; 13(36):9504-15. PubMed ID: 26256756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial cationic peptides that increase nuclease resistance of siRNA without disturbing RNAi activity.
    Maeda Y; Iwata Hara R; Nishina K; Yoshida-Tanaka K; Sakamoto T; Yokota T; Wada T
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(5):338-348. PubMed ID: 30663497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of modified double stranded RNAs containing duplex regions between amide-linked RNA and RNA at both ends and enhanced nuclease resistance.
    Iwase R; Kurokawa R; Ueno J
    Nucleic Acids Symp Ser (Oxf); 2009; (53):119-20. PubMed ID: 19749289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.
    Myers JW; Jones JT; Meyer T; Ferrell JE
    Nat Biotechnol; 2003 Mar; 21(3):324-8. PubMed ID: 12592410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short interfering RNA strand selection is independent of dsRNA processing polarity during RNAi in Drosophila.
    Preall JB; He Z; Gorra JM; Sontheimer EJ
    Curr Biol; 2006 Mar; 16(5):530-5. PubMed ID: 16527750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of 4'-C-aminoalkyl-2'-fluoro-modified RNA oligomers.
    Kano T; Katsuragi Y; Maeda Y; Ueno Y
    Bioorg Med Chem; 2018 Aug; 26(15):4574-4582. PubMed ID: 30097362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of artificial cationic oligodiaminosaccharides and oligopeptides that bind to A-type oligonucleotide duplexes.
    Shiraishi T; Sato K; Hara RI; Wada T
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(8):619-636. PubMed ID: 36850058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional comparison of single- and double-stranded siRNAs in mammalian cells.
    Xu Y; Linde A; Larsson O; Thormeyer D; Elmen J; Wahlestedt C; Liang Z
    Biochem Biophys Res Commun; 2004 Apr; 316(3):680-7. PubMed ID: 15033453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and properties of vitamin E analog-conjugated neomycin for delivery of RNAi drugs to liver cells.
    Iwata R; Nakayama F; Hirochi S; Sato K; Piao W; Nishina K; Yokota T; Wada T
    Bioorg Med Chem Lett; 2015 Feb; 25(4):815-9. PubMed ID: 25597008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of 3'T and 3'TT overhangs to the thermodynamic stability of model siRNA duplexes.
    Lisowiec-Wachnicka J; Znosko BM; Pasternak A
    Biophys Chem; 2019 Mar; 246():35-39. PubMed ID: 30660935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing dual-targeting siRNA duplexes having two active strands that combine siRNA and microRNA-like targeting.
    Sætrom P
    Methods Mol Biol; 2013; 942():169-77. PubMed ID: 23027051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p53-induced Wig-1 protein binds double-stranded RNAs with structural characteristics of siRNAs and miRNAs.
    Méndez Vidal C; Prahl M; Wiman KG
    FEBS Lett; 2006 Aug; 580(18):4401-8. PubMed ID: 16844115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of siRNA.
    Deleavey GF; Watts JK; Damha MJ
    Curr Protoc Nucleic Acid Chem; 2009 Dec; Chapter 16():Unit 16.3. PubMed ID: 20013783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ analysis of single-stranded and duplex siRNA integrity in living cells.
    Raemdonck K; Remaut K; Lucas B; Sanders NN; Demeester J; De Smedt SC
    Biochemistry; 2006 Sep; 45(35):10614-23. PubMed ID: 16939213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of A-type nucleic acid duplexes by novel oligodiaminosaccharides.
    Iwata R; Sudo M; Nagafuji K; Wada T
    Nucleic Acids Symp Ser (Oxf); 2009; (53):113-4. PubMed ID: 19749286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.